Back

WATCH OUR CENTOTALK

Our interactive webinars that feature key developments in clinical diagnostics

  1. Home
  2. Science
  3. NEW CentoXome – Turning Years Into Days

"NEW CentoXome – Turning Years Into Days"

It takes approx. seven years to diagnose a patient with a rare disease. It doesn’t have to be this way.

In this webinar, Maximilian Schmid, M.D., and Jorge Pinto Basto, M.D., share insights into our enhanced Whole Exome Sequencing (WES) solution that is helping physicians around the world overcome the challenges of genetic diagnostics! 

What will you learn about?

  • Intro to the Leader & Trusted Partner in Rare Disease Diagnostics
  • Challenges of Genetic Dx
  • NEW Enhanced Whole Exome Sequencing (WES)
  • Medical Reporting Powered by Our Bio/Databank
  • Our Reclassification Program and Reanalysis



Fill in the form to watch the CentoTalk on demand

By clicking "Watch now!" you agree to receive the latest news and developments in clinical diagnostics and scientific breakthroughs in the rare disease field.

You will receive an email with a subscription confirmation link. Once you have clicked on that link, we will inform you about our products, services and upcoming events per e-mail. You can unsubscribe from our newsletter with effect for the future at any time using the unsubscribe link contained in every newsletter.


Our speakers

Maximilian Schmid, M.D., Chief Commercial Officer – Diagnostics, CENTOGENE


Max has overall responsibility of driving CENTOGENE's Diagnostic business strategy and growth. He joins CENTOGENE from Roche Diagnostics, where he most recently served as Global Head of Medical Affairs of its Sequencing Business Unit...

...He came to Roche following the acquisition of Silicon Valley startup Ariosa Diagnostics Inc., where after a successful career in academic medicine, he helped build a leading global NIPT business.

Prior to his medical career, Max worked as a Management Consultant for McKinsey & Company – developing and implementing strategies and solutions to overcome complex challenges in the pharmaceutical and biotechnology industry. Furthermore, he holds a medical degree from the University of Vienna and is board-certified with habilitation in Obstetrics and Gynecology and sub-specialty training in Maternal-Fetal Medicine, as well as certification in Clinical Genetics.


Jorge Pinto Basto, M.D., Senior Medical Director, CENTOGENE


Jorge serves as CENTOGENE’s Senior Medical Director. Bringing in over 15 years of leadership experience, he is responsible for overseeing policies, management, and regulations to drive clinical and operational value...

...Before joining CENTOGENE, Jorge served as the Director of the Molecular Diagnostics and Genomics Labs at CGC Genetics. He holds a medical degree from the University of Porto and is specialized in Rare Disease Genetics, Neurogenetics, Dysmorphology, and Molecular Genetics.

Jorge is also the President of the Portuguese Society of Human Genetics.